Clinical Trials Browser

Completed × Interventional × Immunotherapy × Clear all

NCT02645149 2026-02-27

Match Mel

Phase 2 Completed

Melanoma

NCT04454489 2025-11-19

Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition

Phase 2 Completed

21 enrolled 18 charts

Squamous Cell Carcinoma of Head and Neck

NCT03176173 2025-11-05

Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL)

Phase NA Completed

45 enrolled 13 charts

Carcinoma, Non-Small-Cell Lung

NCT03426891 2025-10-06

Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma

Phase 1 Completed

21 enrolled 12 charts

Brain Neoplasms, Glioblastoma

NCT03623646 2025-08-08

CITHARE

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck

NCT07015489 2025-06-11

Concurrent Radiotherapy Following Induction Chemoimmunotherapy for Locally Advanced Esophageal Cancer

Phase 2 Completed

ESCC

NCT03035890 2025-04-01

Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer

Phase NA Completed

35 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05902260 2024-09-19

NutriCim

Phase NA Completed

Carcinoma, Non-Small-Cell Lung

NCT02609386 2024-01-30

INSPIRE

Phase 2 Completed

105 enrolled 17 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms

NCT01176474 2023-07-19

Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma

Phase 1 Completed

Melanoma

NCT01176461 2023-01-18

Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558

Phase 1 Completed

Melanoma

NCT04707547 2021-01-13

RFA

Phase 4 Completed

Gastrointestinal

Liver Neoplasms

NCT01675765 2020-09-30

Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma

Phase 1 Completed

60 enrolled 15 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant, Neoplasms

NCT00101166 2018-02-28

Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma

Phase 2 Completed

43 enrolled 6 charts

Melanoma

NCT01347034 2016-05-23

Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS)

Phase 2 Completed

20 enrolled 9 charts

Sarcoma

NCT00673738 2015-10-08

Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC)

Phase 2 Completed

27 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00697671 2013-07-16

Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies

Phase 1 Completed

LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT00186862 2008-06-03

Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma

Phase 1 Completed

Neuroblastoma

NCT00558220 2007-11-14

R-MCEB

Phase 2 Completed

Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse